Clinical Trials
2
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann
Completed
- Conditions
- Age-related Macular Degeneration
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Laurence Postelmans
- Target Recruit Count
- 36
- Registration Number
- NCT04891835
- Locations
- 🇧🇪
CHU Brugmann, Brussels, Belgium
Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients
Completed
- Conditions
- Epiretinal Membrane
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Laurence Postelmans
- Target Recruit Count
- 200
- Registration Number
- NCT03362580
- Locations
- 🇧🇪
CHU Brugmann, Brussels, Belgium
News
No news found